[On the influence of Anturan on ric acid and plasma lipids in patients with gout].
D000328:Adult; D000367:Age Factors; D000368:Aged; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D004035:Diet Therapy; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood; D010949:Plasma / Q000032:analysis; D013442:Sulfinpyrazone / Q000494:pharmacology / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000097:blood*
D005230:Fatty Acids, Nonesterified; D008055:Lipids; D010743:Phospholipids; D014280:Triglycerides; D014527:Uric Acid; D002784:Cholesterol; D013442:Sulfinpyrazone
Uber den Einfluss von Anturan auf Harnsäure und Plasmalipide bei Gichktranken.